CYP1B1-AS1

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, CYP1B1-AS1 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated CYP1B1-AS1 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher CYP1B1-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CYP1B1-AS1 expression acts as an unfavorable survival marker, although some lineages such as ESCA and THCA show a favorable association.

KIRP, ACC, and KIRC are the cancer types where CYP1B1-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
KIRPOSTertileAll0.8570.969<.001123view →
ACCOSMedianII,III,IV0.7490.945<.00164view →
KIRCOSMedianAll0.5450.706<.00163view →
ESCAOSTertileIII,IV0.6610.320.00159view →
THCADFSTertileII,III,IV0.9560.795<.00156view →
LUADOSQuartileAll0.7770.596<.00151view →
LIHCOSMedianAll0.8840.672<.00137view →
MESODFSTertileIV0.5170.105.00124view →
GBMDFSMedianAll0.2050.304.01024view →
LAMLDFSMedianAll0.2630.518.00922view →
CHOLDFSMedianAll0.6830.122.00821view →
OVDFSMedianIV0.3370.558.00518view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

CYP1B1-AS1–KIRP (OS)

Kaplan–Meier survival curve for CYP1B1-AS1 RNA-high vs -low samples in KIRP.

Open the KIRP breakdown →

Exploration